Gliclazide/Metformin Hydrochloride

格列齐特/盐酸二甲双胍

Report date: 2023/02/09 14:15:24

Base Information

Drug NameGliclazide/Metformin Hydrochloride
Drug Alias Name格列齐特+盐酸二甲双胍Gliclazide+Metformin HydrochlorideMetformin Hydrochloride/Gliclazide盐酸二甲双胍+格列齐特Metformin Hydrochloride+Gliclazide +[6] 
ClassificationSmall molecules
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsSulfonylurea receptor agonists
TargetsSulfonylurea receptorProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryMainland China
Original Approved Date2005/01/01
Country/TerritoryMexicoMainland China
CombinationsYes Metformin HydrochlorideGliclazide
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Lianhuan Pharmaceutical Co Ltd
Inactive CompaniesMerck KGaA, Darmstadt, Germany
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A